P062: The efficacy and safety of nivolumab 40 mg therapy versus 3 mg/kg in patients with relapsed and refractory classic Hodgkin lymphoma

ABSTRACT:

SUBMITTER: Fedorova L 

PROVIDER: S-EPMC9621487 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature